Split History
ETFs Holding ATOS »    ATOS Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Atossa Genetics is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. Co.'s principal program uses its patented intraductal microcatheters which deliver pharmaceuticals through the breast ducts. Co.'s second development program involves the drug endoxifen, which is a potential treatment for post-breast cancer therapy, preventative therapy as well as a potential therapy for breast density and other breast health conditions. Co.'s medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator, and a universal transport kit to transport NAF samples. According to our ATOS split history records, Atossa Genetics has had 2 splits.
ATOS split history picture
Atossa Genetics (ATOS) has 2 splits in our ATOS split history database. The first split for ATOS took place on August 26, 2016. This was a 1 for 15 reverse split, meaning for each 15 shares of ATOS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. ATOS's second split took place on April 20, 2018. This was a 1 for 12 reverse split, meaning for each 12 shares of ATOS owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 5.55555555555556 share position following the split.

When a company such as Atossa Genetics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ATOS split history from start to finish, an original position size of 1000 shares would have turned into 5.55555555555556 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Atossa Genetics shares, starting with a $10,000 purchase of ATOS, presented on a split-history-adjusted basis factoring in the complete ATOS split history. ATOS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/08/2012
End date: 07/18/2018
Start price/share: $864.00
End price/share: $2.47
Dividends collected/share: $0.00
Total return: -99.71%
Average Annual Total Return: -64.28%
Starting investment: $10,000.00
Ending investment: $28.57
Years: 5.69
Date Ratio
08/26/20161 for 15
04/20/20181 for 12
ATOS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ATRC Split History
ATRI Split History
AVGR Split History
AVXL Split History
AZN Split History
BAX Split History
BCR Split History
BDMS Split History
BDX Split History
BGMD Split History

Also explore: ATOS shares outstanding history

Frontera Energy Corporation (FEC.CA)
Dollarama Inc. (DOL.CA)
TMSR Holding Company Limited (TMSR)
ReShape Lifesciences Inc. (RSLS)
Jaguar Health, Inc. (JAGX)
Gevo, Inc. (GEVO)
Trovagene, Inc. (TROV)
Exponent, Inc. (EXPO)
ContraVir Pharmaceuticals, Inc. (CTRV)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ATOS Insider Buying

ATOS Split History | www.SplitHistory.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.